First-line immunochemotherapy for advanced NSCLC in Asian patients: a meta-analysis of phase 3 RCTs
{{output}}
Background: PD-1/PD-L1 inhibitors plus chemotherapy (PC) are now broadly acknowledged as effective for treating stage IIIb-IV non-small cell lung cancer (NSCLC). However, data specific to Asian populations remain limited, and upd... ...
